Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Rezolute Inc

RZLT
Current price
5.6 USD -0.01 USD (-0.18%)
Last closed 5.64 USD
ISIN US76200L3096
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 312 077 664 USD
Yield for 12 month +645.67 %
1Y
3Y
5Y
10Y
15Y
RZLT
21.11.2021 - 28.11.2021

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. The company's lead product candidate is ersodetug, a human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder. It also developing RZ402, an oral plasma kallikrein inhibitor, which is in Phase 2 clinical trial for the chronic treatment of diabetic macular edema. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was incorporated in 2010 and is headquartered in Redwood City, California. Address: 275 Shoreline Drive, Redwood City, CA, United States, 94065

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

13 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

+58 000 USD

Current Year

-36 000 USD

Last Year

-382 000 USD

Current Quarter

Last Quarter

+51 000 USD

Key Figures RZLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -70 387 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -34.33 %
PEG Ratio
Return On Equity TTM -57.73 %
Wall Street Target Price 13 USD
Revenue TTM
Book Value 2.27 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.33 USD
Diluted Eps TTM -1.33 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics RZLT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History RZLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:50
Payout Ratio
Last Split Date 13.10.2020
Dividend Date 13.10.2020

Stock Valuation RZLT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.0113
Price Book MRQ 2.5606

Financials RZLT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators RZLT

For 52 weeks

0.72 USD 6.19 USD
50 Day MA 5.05 USD
Shares Short Prior Month 1 078 089
200 Day MA 3.65 USD
Short Ratio 3.16
Shares Short 1 148 577
Short Percent 2.84 %